摘要
Dear readers,We are happy to bring to you this special issue,the focus of which is the impact of Covid-19 pandemic in the management of cancer patients who naturally form a high risk cohort because of their immune compromised status.There are considerable problems of managing an organized safe workflow for health care systems in delivering treatment without compromising survival.One probable solution would involve adapting cancer protocols supported by scientific data that can provide shorter treatment times/easier or faster treatment delivery.Exploring this landscape,we have in this edition a review article on adapting newer treatment protocols for managing cervical cancers,one of the top female malignancies worldwide.In addition to the theme this issue contains the regular article focusing on modern cancer research.Triple Negative Breast Cancer form a very unfavorable cohort with an aggressive behavior and a relatively poor response to current treatments especially when presenting in the metastatic setup.The newer insights on molecular subtypes and mutations within TNBC has allowed for the evolution of promising new treatment options including targeted therapies,immune check point inhibitors and antibody drug conjugates.We have a systemic review covering the promising new options and the probable scientific rationale and evidence currently supporting them.
